Rapid mood-elevating effects of low field magnetic stimulation in depression

Biological Psychiatry

Volumn 76, Issue 3, 2014, Pages 186-193

  Rohan, Michael L ^a   Yamamoto, Rinah T ^a   Ravichandran, Caitlin T ^b   Cayetano, Kenroy R ^a   Morales, Oscar G ^b   Olson, David P ^a   Vitaliano, Gordana ^b   Paul, Steven M ^b   Cohen, Bruce M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Bipolar depression; depression; electromagnetic field; field; rapid antidepressant; therapy

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; BRAIN CORTEX; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; ELECTROMAGNETIC FIELD; FEMALE; HAMILTON SCALE; HUMAN; LOW FIELD MAGNETIC STIMULATION; MAGNETIC STIMULATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD; NERVE STIMULATOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITIVE AND NEGATIVE AFFECT SCHEDULE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE; AFFECT; BRAIN; DEPRESSIVE DISORDER, MAJOR; DEVICES; MAGNETOTHERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME;

ADULT; AFFECT; BIPOLAR DISORDER; BRAIN; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; MAGNETIC FIELD THERAPY; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84903980617     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.10.024     Document Type: Article

References (62)

1. R.C. Kessler, P. Berglund, O. Demler, R. Jin, K.R. Merikangas, and E.E. Walters Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch Gen Psychiatry 62 2005 593 602
2. K.R. Merikangas, R. Jin, J.-P. He, R.C. Kessler, S. Lee, and N.A. Sampson et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative Arch Gen Psychiatry 68 2011 241 251
3. World Health Organization The Global Burden of Disease: 2004 Update 2008 World Health Organization Geneva
4. L.L. Judd, H.S. Akiskal, P.J. Schettler, J. Endicott, J. Maser, and D.A. Solomon et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder Arch Gen Psychiatry 59 2002 530 537
5. G.S. Sachs, A.A. Nierenberg, J.R. Calabrese, L.B. Marangell, S.R. Wisniewski, and L. Gyulai et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression N Engl J Med 356 2007 1711 1722
6. R.D. Gibbons, K. Hur, C.H. Brown, J.M. Davis, and J.J. Mann Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine Arch Gen Psychiatry 69 2012 572 579
7. J. Moncrieff, and I. Kirsch Efficacy of antidepressants in adults BMJ 331 2005 155 157
8. I. Kirsch, B.J. Deacon, T.B. Huedo-Medina, A. Scoboria, T.J. Moore, and B.T. Johnson Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration PLoS Med 5 2008 e45
9. M. Fava, A.J. Rush, J.E. Alpert, G.K. Balasubramani, S.R. Wisniewski, and C.N. Carmin et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report Am J Psychiatry 165 2008 342 351
10. S.C. Sung, C.L. Haley, S.R. Wisniewski, M. Fava, A.A. Nierenberg, and D. Warden et al. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations J Clin Psychiatry 73 2012 967 976
11. A.J. Rush, M.H. Trivedi, S.R. Wisniewski, A.A. Nierenberg, J.W. Stewart, and D. Warden et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report Am J Psychiatry 163 2006 1905 1917
12. H.J. Conradi, J. Ormel, and P. de Jonge Symptom profiles of DSM-IV-defined remission, recovery, relapse, and recurrence of depression: The role of the core symptoms Depress Anxiety 29 2012 638 645
13. D. Souery, A. Serretti, R. Calati, P. Oswald, I. Massat, and A. Konstantinidis et al. Switching antidepressant class does not improve response or remission in treatment-resistant depression J Clin Psychopharmacol 31 2011 512 516
14. T.E. Schlaepfer, H. Agren, P. Monteleone, C. Gasto, W. Pitchot, and F. Rouillon et al. The hidden third: Improving outcome in treatment-resistant depression J Psychopharmacol 26 2012 587 602
15. G.S. Leverich, L.L. Altshuler, M.A. Frye, T. Suppes, S.L. McElroy, and P.E. Keck Jr et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers Am J Psychiatry 163 2006 232 239
16. M. Bauer, P. Ritter, H. Grunze, and A. Pfennig Treatment options for acute depression in bipolar disorder Bipolar Disord 14 suppl 2 2012 37 50
17. J.M. Dupuy, M.J. Ostacher, J. Huffman, R.H. Perlis, and A.A. Nierenberg A critical review of pharmacotherapy for major depressive disorder Int J Neuropsychopharmacol 14 2011 1417 1431
18. A. Merkl, I. Heuser, and M. Bajbouj Antidepressant electroconvulsive therapy: Mechanism of action, recent advances and limitations Exp Neurol 219 2009 20 26
19. S.S. Husain, I.M. Kevan, R. Linnell, and A.I.F. Scott Electroconvulsive therapy in depressive illness that has not responded to drug treatment J Affect Disord 83 2004 121 126
20. S.H. Lisanby Electroconvulsive therapy for depression N Engl J Med 357 2007 1939 1945
21. M. Nordentoft, P.B. Mortensen, and C.B. Pedersen Absolute risk of suicide after first hospital contact in mental disorder Arch Gen Psychiatry 68 2011 1058 1064
22. C.A. Zarate, J.B. Singh, P.J. Carlson, N.E. Brutsche, R. Ameli, and D.A. Luckenbaugh et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression Arch Gen Psychiatry 63 2006 856 864
23. N. Diazgranados, L. Ibrahim, N.E. Brutsche, A. Newberg, P. Kronstein, and S. Khalife et al. A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression Arch Gen Psychiatry 67 2010 793 802
24. M.L. Furey, and W.C. Drevets Antidepressant efficacy of the antimuscarinic drug scopolamine: A randomized, placebo-controlled clinical trial Arch Gen Psychiatry 63 2006 1121 1129
25. W.C. Drevets, and M.L. Furey Replication of scopolamine's antidepressant efficacy in major depressive disorder: A randomized, placebo-controlled clinical trial Biol Psychiatry 67 2010 432 438
26. A.M. Lozano, P. Giacobbe, C. Hamani, S.J. Rizvi, S.H. Kennedy, and T.T. Kolivakis et al. A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression J Neurosurg 116 2012 315 322
27. T.E. Schlaepfer, B.H. Bewernick, S. Kayser, B. Madler, and V.A. Coenen Rapid effects of deep brain stimulation for treatment-resistant major depression Biol Psychiatry 73 2013 1204 1212
28. P.E. Holtzheimer, M.E. Kelley, R.E. Gross, M.M. Filkowski, S.J. Garlow, and A. Barrocas et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression Arch Gen Psychiatry 69 2012 150 158
29. B.H. Bewernick, S. Kayser, V. Sturm, and T.E. Schlaepfer Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: Evidence for sustained efficacy Neuropsychopharmacology 37 2012 1975 1985
30. B.G. Bunney, and W.E. Bunney Mechanisms of rapid antidepressant effects of sleep deprivation therapy: Clock genes and circadian rhythms Biol Psychiatry 73 2013 1164 1171
31. M. Rohan, A. Parow, A.L. Stoll, C. Demopulos, S. Friedman, and S. Dager et al. Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator Am J Psychiatry 161 2004 93 98
32. S. Posse, S.R. Dager, T.L. Richards, C. Yuan, R. Ogg, and A.A. Artru et al. In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: Proton echo planar spectroscopic imaging (PEPSI) Magn Reson Med 37 1997 858 865
33. W.A. Carlezon, M.L. Rohan, S.D. Mague, E.G. Meloni, A. Parsegian, and K. Cayetano et al. Antidepressant-like effects of cranial stimulation within a low-energy magnetic field in rats Biol Psychiatry 57 2005 571 576
34. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: A new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
35. D.V. Sheehan, Y. Lecrubier, K.H. Sheehan, P. Amorim, J. Janavs, and E. Weiller et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 suppl 20 1998 22 33 quiz 34-57
36. M. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
37. D. Watson, L.A. Clark, and A. Tellegen Development and validation of brief measures of positive and negative affect: The PANAS scales J Pers Soc Psychol 54 1988 1063 1070
38. M. London, and M. Häusser Dendritic computation Annu Rev Neurosci 28 2005 503 532
39. J.S. Long Using heteroscedasticity consistent standard errors in the linear regression model Am Stat 54 2000 217 224
40. J.G. Mackinnon The interpretation of test statistics Can J Econ 18 1985 38 57
41. National Institute for Clinical Excellence (NICE) Depression: Management of Depression in Primary and Secondary Care Clinical Guideline 23 2004 The British Psychological Society, The Royal College of Psychiatrists London
42. M.S. George, S.H. Lisanby, D. Avery, W.M. McDonald, V. Durkalski, and M. Pavlicova et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial Arch Gen Psychiatry 67 2010 507 516
43. P.C. Miranda, M. Hallett, and P.J. Basser The electric field induced in the brain by magnetic stimulation: A 3-D finite-element analysis of the effect of tissue heterogeneity and anisotropy IEEE Trans Biomed Eng 50 2003 1074 1085
44. H.S. Mayberg Targeted electrode-based modulation of neural circuits for depression J Clin Invest 119 2009 717 725
45. A.M. Lozano, H.S. Mayberg, P. Giacobbe, C. Hamani, R.C. Craddock, and S.H. Kennedy Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression Biol Psychiatry 64 2008 461 467
46. S. Silva, P.J. Basser, and P.C. Miranda Elucidating the mechanisms and loci of neuronal excitation by transcranial magnetic stimulation using a finite element model of a cortical sulcus Clin Neurophysiol 119 2008 2405 2413
47. F. Fröhlich, and D.A. McCormick Endogenous electric fields may guide neocortical network activity Neuron 67 2010 129 143
48. C.A. Anastassiou, S.M. Montgomery, M. Barahona, G. Buzsáki, and C. Koch The effect of spatially inhomogeneous extracellular electric fields on neurons J Neurosci 30 2010 1925 1936
49. J.K. Deans, A.D. Powell, and J.G.R. Jefferys Sensitivity of coherent oscillations in rat hippocampus to AC electric fields J Physiol 583 2007 555 565
50. J.T. Francis, B.J. Gluckman, and S.J. Schiff Sensitivity of neurons to weak electric fields J Neurosci 23 2003 7255 7261
51. D. Tranchina, and C. Nicholson A model for the polarization of neurons by extrinsically applied electric fields Biophys J 50 1986 1139 1156
52. T. Branco, and M. Häusser Synaptic integration gradients in single cortical pyramidal cell dendrites Neuron 69 2011 885 892
53. D. Ledergerber, and M.E. Larkum Properties of layer 6 pyramidal neuron apical dendrites J Neurosci 30 2010 13031 13044
54. N. Spruston Pyramidal neurons: Dendritic structure and synaptic integration Nat Rev Neurosci 9 2008 206 221
55. N.D. Volkow, D. Tomasi, G.-J. Wang, J.S. Fowler, F. Telang, and R. Wang et al. Effects of low-field magnetic stimulation on brain glucose metabolism Neuroimage 51 2010 623 628
56. Z.D. Deng, S.H. Lisanby, and A.V. Peterchev Electric field depth-focality tradeoff in transcranial magnetic stimulation: Simulation comparison of 50 coil designs Brain Stimul 6 2013 1 13
57. J. Savitz, and W.C. Drevets Bipolar and major depressive disorder: Neuroimaging the developmental-degenerative divide Neurosci Biobehav Rev 33 2009 699 771
58. K.J. Ressler, and H.S. Mayberg Targeting abnormal neural circuits in mood and anxiety disorders: From the laboratory to the clinic Nat Neurosci 10 2007 1116 1124
59. Y.I. Sheline, J.L. Price, Z. Yan, and M.A. Mintun Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus Proc Natl Acad Sci U S A 107 2010 11020 11025
60. C. McCabe, and Z. Mishor Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers Neuroimage 57 2011 1317 1323
61. J.S. Perrin, S. Merz, D.M. Bennett, J. Currie, D.J. Steele, I.C. Reid, and C. Schwarzbauer Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder Proc Natl Acad Sci U S A 109 2012 5464 5468
62. R.W. Pryor Multiphysics Modeling Using Comsol V.4: A First Principles Approach. 2012 Mercury Learning & Information Brunswick, MD